the ceo locations leadership management team board of directors collaborations strategic partners products products products products overview united states aristada vivitrol u.s. products using alkermes technologies european union eu products using alkermes technologies research & development research & development research & development r & d overview our r & d approach pipeline technology platforms manufacturing other information clinical trials expanded access responsibility responsibility responsibility alkermes corporate giving investigator initiated trials educational grants patient engagement support alkermes inspiration grants investors investors investors corporate overview press releases investor events stock information sec filings annual reports financials snapshot trading statistics other information email alerts news & events news & events news & events press releases media kit careers careers careers working at alkermes meet alkermes employees search jobs benefits employee faqs science with a purpose alkermes applies its scientific expertise and technological know how to develop innovative medicines designed to help patients with serious chronic conditions better manage their disease . our company latest news alkermes announces initiation of clinical study evaluating metabolic profile of alks 3831 for treatment of schizophrenia read more alkermes announces webcast of analyst and investor event on september 26 2016 read more alkermes launches competitive grants program to support people affected by mental health and substance use disorders read more investors learn more pipeline see our approach working at alkermes join our team you are now leaving alkermes.com . about us our company message from the ceo locations management team board of directors strategic partners products products overview aristada vivitrol u.s. products using alkermes technologies eu products using alkermes technologies research & development r & d overview our r & d approach pipeline technology platforms manufacturing clinical trials expanded access responsibility alkermes corporate giving investigator initiated trials educational grants patient engagement support alkermes inspiration grants investors corporate overview press releases investor events stock information sec filings annual reports snapshot trading statistics email alerts news & events press releases media kit careers working at alkermes meet alkermes employees search jobs benefits employee faqs 2016 alkermes . all rights reserved terms of use privacy policy